Name: QUANTERIX CORP (QTRX) Stock
Brand: QUANTERIX CORP
Rating: 3.5 (3 reviews)

QTRX Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Zacks Investment Research

All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy

2 months ago - By: Quanterix Corporation

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

3 months ago - By: Zacks Investment Research

Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)

3 months ago - By: Quanterix Corporation

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

3 months ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

3 months ago - By: Benzinga

Earnings Preview: Quanterix

3 months ago - By: Zacks Investment Research - Mentions: CAPR

Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates

3 months ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the Second Quarter of 2025

3 months ago - By: Quanterix Corporation

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

3 months ago - By: Quanterix Corporation

Quanterix Announces Cooperation Agreement with Kent Lake Capital

3 months ago - By: Quanterix Corporation

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

4 months ago - By: Quanterix Corporation

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Quanterix Corporation

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

4 months ago - By: Quanterix Corporation

Quanterix Expands Reach with IVD and Large Reference Labs

5 months ago - By: Quanterix Corporation

Quanterix to Present at Goldman Sachs Global Healthcare Conference

5 months ago - By: Kent Lake PR LLC - Mentions: AKYA

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

6 months ago - By: Zacks Investment Research - Mentions: MDT

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the First Quarter of 2025

6 months ago - By: Zacks Investment Research - Mentions: PAHC

Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates

6 months ago - By: Quanterix Corporation

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

6 months ago - By: Kent Lake PR LLC

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

6 months ago - By: Quanterix Corporation - Mentions: AKYA

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

7 months ago - By: Halper Sadeh LLC - Mentions: BRDG AKYA CKPT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

7 months ago - By: Kent Lake PR LLC

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

7 months ago - By: Kent Lake PR LLC

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

7 months ago - By: Quanterix Corporation

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

8 months ago - By: Quanterix Corporation

QUANTERIX CORP (QTRX) Stock News

QTRX Latest News, Press Relases and Analysis

All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Earnings Scheduled For August 7, 2025

Earnings Preview: Quanterix

Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates

Quanterix Releases Financial Results for the Second Quarter of 2025

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Quanterix Expands Reach with IVD and Large Reference Labs

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

Quanterix Releases Financial Results for the First Quarter of 2025

Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Quanterix Releases Financial Results for the Fourth Quarter of 2024